Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-09Clinical Trial Update: TALENT Study: Phase II Trial of Adjuvant L-TIL Plus Tislelizumab in Resectable NSCLC Without pCR After Neoadjuvant Chemoimmunotherapy [Phase 2]
This clinical trial update describes a Phase II adjuvant therapy study in resectable non-small cell lung cancer using L-TIL plus tislelizuma…
-
CLINICAL_TRIALS research · 2026-01-09Clinical Trial Update: Patient-derived Tumor-like Cell Cluster Model-based Precision Treatment Strategy on Non-small Cell Lung Cancer
This clinical trial update describes a precision treatment strategy for non-small cell lung cancer using patient-derived tumor-like cell clu…
-
CLINICAL_TRIALS research · 2026-01-09Clinical Trial Update: Circulating Tumor DNA Guided Treatment Monitoring in Advanced Lung Cancer [NA]
A clinical trial evaluating circulating tumor DNA guided treatment monitoring in advanced non-small cell lung cancer is currently recruiting…
-
FDA approval · 2026-01-08FDA Approved: ENSACOVE — Supplemental Application (Xcovery Holdings, Inc.)
FDA approved ENSACOVE's supplemental application for ensartinib submitted by Xcovery Holdings, Inc.
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: A Study Investigating the Outcomes and Safety of Atezolizumab Under Real-World Conditions in Patients Treated in Routine Clinical Practice
This clinical trial update reports on real-world outcomes and safety of atezolizumab in routine practice. It includes patients with urotheli…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: A Platform Study of Novel Immunotherapy Combinations in Participants With Previously Untreated, Advanced/Metastatic Non-Small-Cell Lung Cancer [Phase 2]
Phase 2 platform study evaluating novel immunotherapy combinations in previously untreated, advanced/metastatic non-small cell lung cancer; …
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: Tumor Treating Fields for Locally Advanced NSCLC [Phase 1]
A Phase 1 clinical trial evaluating Tumor Treating Fields for locally advanced non-small cell lung cancer is currently recruiting at the Uni…
-
CLINICAL_TRIALS trial_result · 2026-01-08Clinical Trial Update: Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer [Phase 3]
This is a Phase 3 clinical trial evaluating a first-line treatment regimen of trastuzumab deruxtecan, pembrolizumab, and platinum-based chem…
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: Osimertinib With Chemotherapy as First-line Therapy for EGFR Mutation-positive NSCLC
Update on a clinical trial evaluating the combination of osimertinib with chemotherapy as first-line therapy for EGFR mutation-positive non-…
-
CLINICAL_TRIALS trial_result · 2026-01-08Clinical Trial Update: Study of Nivolumab-Ipilimumab and cfDNA in Lung Cancer [Phase 2]
Phase 2 study evaluating the combination of nivolumab and ipilimumab with circulating tumor DNA assessment in non-small cell lung cancer was…
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: Molecular Phenotyping of Primitive Lung Cancer and Metastatic Site
A clinical trial led by the European Institute of Oncology is investigating molecular phenotyping of primary lung cancer and its metastatic …
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: Placebo-controlled Study Comparing Niraparib Plus Pembrolizumab Versus Placebo Plus Pembrolizumab as Maintenance Therapy in Participants With Advanced/Metastatic Non-Small Cell Lung Cancer [Phase 3]
A Phase 3 clinical trial is evaluating niraparib plus pembrolizumab versus placebo plus pembrolizumab as maintenance therapy in adults with …
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: A Pilot Phase II Study of Maintenance Cabozantinib Plus Pembrolizumab for Patients With Metastatic Squamous Non-Small Cell Lung Cancer (sqNSCLC) [Phase 2]
A pilot Phase II clinical trial is evaluating maintenance cabozantinib plus pembrolizumab for metastatic squamous non-small cell lung cancer…
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: Phase 2 Study of TVB-2640 in KRAS Non-Small Cell Lung Carcinomas [Phase 2]
A Phase 2 clinical trial of TVB-2640 in KRAS-mutant non-small cell lung cancer is listed as active but not recruiting.
-
EMA approval · 2026-01-08EMA Authorised: Xalkori (crizotinib) — Pfizer Europe MA EEIG
The European Medicines Agency authorised Xalkori (crizotinib) for non-small cell lung cancer with Pfizer Europe MA EEIG as the marketing aut…
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: Integrated Molecular Profiling in Advanced Cancers Trial
An ongoing trial, Integrated Molecular Profiling in Advanced Cancers, sponsored by University Health Network in Toronto, investigates using …
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: Urolithin A in Patients With Previously Untreated Solid Tumors Receiving Immune Checkpoint Inhibitors [NA]
This entry reports a recruiting clinical trial evaluating urolithin A in patients with previously untreated solid tumors receiving immune ch…
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies
A clinical trial funded by Elephas is exploring a biomarker-based method to predict response to immunotherapy using live tumor biopsies; the…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients [Phase 3]
Phase 3 study of Ivonescimab for first-line treatment of metastatic non-small cell lung cancer is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-01-07Clinical Trial Update: Hybrid Dose-fraction Radiotherapy for Metastatic Non-small Cell Lung Cancer [Phase 2]
A Phase 2 clinical trial evaluating hybrid dose-fraction radiotherapy for metastatic non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2026-01-07Clinical Trial Update: A Study Describing Real-World Effectiveness of Nivolumab + Chemotherapy in Neoadjuvant NSCLC
A completed real-world study assessed the effectiveness of nivolumab plus chemotherapy as neoadjuvant therapy for non-small cell lung cancer…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: Carboplatin, Taxane And Ramucirumab for Patients With NSCLC After Pemetrexed or Pembrolizumab Maintenance [Phase 2]
A Phase 2 clinical trial evaluating the combination of carboplatin, a taxane, and ramucirumab for patients with non-small cell lung cancer a…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: High Dose Dexamethasone to Reduce Postoperative Pain After Video-Assisted Thoracoscopic Surgery Lobectomy /Segmentectomy [Phase 2, Phase 3]
A Phase 2/3 trial is evaluating high-dose dexamethasone to reduce postoperative pain after video-assisted thoracoscopic surgery lobectomy/se…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: Tocilizumab and Atezolizumab in Adults With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Refractory to 1st Line Immune Checkpoint Inhibitor-Based Therapy [Phase 1, Phase 2]
This clinical trial evaluates the combination of tocilizumab and atezolizumab in adults with locally advanced or metastatic non-small cell l…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas [Phase 1]
DR-0202 is being studied in a Phase 1 trial across multiple locally advanced or metastatic carcinomas; the study is currently recruiting.